Discover 1,743 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,743
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Location: Ann Arbor MI, Nashville TN, New York NY, Boston MA,
Sponsor: Remix Therapeutics
Sex: All
Age: 18+
Code: NCT06118086
Phase1, Phase2, Recruiting
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
for
Oropharyngeal Cancer
Location: Ann Arbor MI, Brighton MI, Detroit MI, Cleveland OH,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT05451004
Phase3, Recruiting
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
for
Prostate Cancer
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: Male
Age: 40 - 70+
Code: NCT05965180
Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Ann Arbor MI, Columbus OH, Chicago IL, Toronto,
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06561048
Phase3, Recruiting
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Ann Arbor MI, Detroit MI, Toronto, Denver CO,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06253130
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Ann Arbor MI, Detroit MI, Grand Rapids MI, Cleveland OH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase3, Recruiting
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
for
Intracranial Meningioma
Location: Ann Arbor MI, Indianapolis IN, Milwaukee WI,
Sponsor: RTOG Foundation, Inc.
Sex: All
Age: 18+
Code: NCT06955169
Phase2, Recruiting
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05256225
Phase3, Recruiting
Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma
for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT07630155
Recruiting
Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
for
Prostate Carcinoma
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: Male
Age: 35 - 70
Code: NCT07645391
Recruiting
Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma
for
Recurrent B Acute Lymphoblastic Leukemia,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT07532525
Phase1, Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
for
Astrocytoma, IDH-Mutant, Grade 3
Location: Ann Arbor MI, Brighton MI, Wyoming MI, Grand Rapids MI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 12+
Code: NCT07215910
Phase3, Recruiting
A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial
for
Anatomic Stage 0 Breast Cancer AJCC v8,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 0+
Code: NCT07443943
Phase2, Recruiting
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: Ann Arbor MI, Detroit MI, Kalamazoo MI, Grand Rapids MI,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase2, Phase3, Recruiting
A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment
for
Chemotherapy-Induced Peripheral Neuropathy,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT07365007
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Ann Arbor MI, Brighton MI, Novi MI, West Bloomfield MI,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07097142
Phase3, Recruiting
Obeticholic Acid for Prevention in Barrett's Esophagus
for
Barrett Esophagus, Esophageal Adenocarcinoma
Location: Ann Arbor MI, Cleveland OH, St Louis MO, Chapel Hill NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04939051
Phase2, Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Ann Arbor MI, Brighton MI, Farmington Hills MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07195734
Phase2, Recruiting
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
for
Familial Adenomatous Polyposis
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT06641310
Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Ann Arbor MI, Columbus OH, Chicago IL, Glenview IL,